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The G Protein–Gated Potassium Current IK,ACh Is Constitutively
Active in Patients With Chronic Atrial Fibrillation
D. Dobrev, MD; A. Friedrich, CandMed; N. Voigt, CandMed; N. Jost, PhD; E. Wettwer, PhD;
T. Christ, MD; M. Knaut, MD; U. Ravens, MD
Background—The molecular mechanism of increased background inward rectifier current (IK1) in atrial fibrillation (AF)
is not fully understood. We tested whether constitutively active acetylcholine (ACh)-activated IK,ACh contributes to
enhanced basal conductance in chronic AF (cAF).
Methods and Results—Whole-cell and single-channel currents were measured with standard voltage-clamp
techniques in atrial myocytes from patients with sinus rhythm (SR) and cAF. The selective IK,ACh blocker tertiapin
was used for inhibition of IK,ACh. Whole-cell basal current was larger in cAF than in SR, whereas carbachol
(CCh)-activated IK,ACh was lower in cAF than in SR. Tertiapin (0.1 to 100 nmol/L) reduced IK,ACh in a
concentration-dependent manner with greater potency in cAF than in SR (logIC50: 9.1 versus 8.2; P0.05). Basal
current contained a tertiapin-sensitive component that was larger in cAF than in SR (tertiapin [10 nmol/L]-sensitive
current at 100 mV: cAF, 6.71.2 pA/pF, n16/5 [myocytes/patients] versus SR, 1.70.5 pA/pF, n24/8),
suggesting contribution of constitutively active IK,ACh to basal current. In single-channel recordings, constitutively
active IK,ACh was prominent in cAF but not in SR (channel open probability: cAF, 5.40.7%, n19/9 versus SR,
0.10.05%, n16/9; P0.05). Moreover, IK1 channel open probability was higher in cAF than in SR (13.40.4%,
n19/9 versus 11.40.7%, n16/9; P0.05) without changes in other channel characteristics.
Conclusions—Our results demonstrate that larger basal inward rectifier K current in cAF consists of increased IK1
activity and constitutively active IK,ACh. Blockade of IK,ACh may represent a new therapeutic target in AF.
(Circulation. 2005;112:3697-3706.)
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Atrial fibrillation (AF) is the most frequent cardiac ar-rhythmia in the clinical setting. It is associated with
shorter action potential duration (APD) and effective refrac-
tory period and a loss of rate-dependent APD adaptation that
involve concomitant alterations in ion current activity.1,2 Ion
channel remodeling in patients with chronic AF (cAF) in-
cludes decreased density of L-type Ca2 currents (ICa,L) and
increased amplitude of the background inward rectifier K
current IK1.3–8 The changes in atrial electrical properties
(electrical remodeling) promote induction of AF and the
tendency of the arrhythmia to be sustained.1 The autonomic
nervous system may also contribute to initiation and persis-
tence of AF. Vagal stimulation reduces atrial APD and
effective refractory period and increases dispersion of atrial
repolarization.9 This creates an arrhythmogenic substrate for
reentry of the excitation wavefront, which promotes the
duration of the AF episodes.1 Although it is generally
accepted that vagal nerve activation contributes to initiation
of AF, its precise role in cAF and the underlying molecular
mechanisms are currently unknown.
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Vagally released acetylcholine (ACh) stimulates musca-
rinic receptors (M-receptors) and activates the atrial ACh-
regulated potassium current IK,ACh.10 The resulting shorten-
ing of APD in response to M-receptor stimulation is
mediated by IK,ACh because in knockout mice lacking this
channel, M-receptor stimulation did not induce AF.11
Therefore, increased activity of IK,ACh was expected to
contribute to induction or perpetuation of AF. Studies in
atrial biopsies from patients with cAF revealed, however,
that both expression of the Kir3.1 and Kir3.4 channel
subunits and activation of whole-cell IK,ACh in response to
M-receptor stimulation were lower in AF than in sinus
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rhythm (SR).6,7,12,13 This was interpreted as an adaptation
of atrial myocytes to the high beating rate by reducing
IK,ACh to counteract the shortening of APD.2
Reduced M-receptor–mediated activation of IK,ACh in AF
compared with SR is associated with higher IK1 ampli-
tude.3,4,6,7,14,15 Although larger amplitude of IK1 during AF
is paralleled by increased mRNA and protein levels of the
Kir2.1 channel subunit,6,15 the molecular basis of increased
IK1 remains incompletely understood. One possibility is
that IK,ACh or the ATP-regulated inward rectifier IK,ATP,
which cannot be distinguished electrophysiologically at
the whole-cell level, contributes to background IK1 by
developing spontaneous activity. Therefore, throughout
the remainder of this report, inward rectifier current in the
absence of agonists is called basal current rather than IK1.
Theoretically, each component of the M-receptor–medi-
ated signal transduction, including IK,ACh, may develop
spontaneous activity in the absence of abnormal vagal
tone. For instance, dog atrial myocytes possess a consti-
tutively active IK,ACh-like current that develops higher
amplitude after 1 week of atrial tachypacing.16 Hence,
constitutively active IK,ACh channels may also exist in atria
of AF patients.
The present study tested the hypothesis that increased IK1
in patients with cAF consists of enhanced IK1 and consti-
tutively active IK,ACh current components.
Methods
Human Samples
The study was approved by the local ethics committee of the
university (No. EK790799), and each patient gave written informed
consent.
Right atrial appendages were obtained from 46 patients with SR
and 33 patients with cAF (cAF 6 months; Table 1).
Electrophysiological Recordings
Atrial myocytes were isolated with the use of our previous protocol17
and were suspended in storage solution (in mmol/L: KCl 20, KH2PO4
10, glucose 10, K-glutamate 70, -hydroxybutyrate 10, taurine 10,
EGTA 10, albumin 1, pH 7.4). Membrane currents were measured
with standard whole-cell voltage-clamp techniques. ISO-2 software
(MFK) was used for whole-cell and single-channel data acquisition
and analysis.
For whole-cell measurements, borosilicate glass microelec-
trodes had tip resistances of 1 to 2 M when filled with pipette
solution (in mmol/L: K-aspartate 100, NaCl 10, KCl 40, Mg-ATP
5, EGTA 2, GTP-Tris 0.1, HEPES 10, pH 7.4). Myocytes were
superfused with a solution containing the following (in mmol/L):
NaCl 120, KCl 20, MgCl2 1, CaCl2 2, glucose 10, HEPES 10, pH
7.4 at 22°C to 24°C. Seal resistances were 4 to 8 G. Series
resistance and cell capacitance were compensated. Basal current
was measured by applying a depolarizing ramp pulse from 100
to 40 mV (holding potential 80 mV; see inset in Figure 1A).
IK,ACh was stimulated with the nonselective M-receptor agonist
carbachol (CCh) (2 mol/L) and was identified with the selective
bee venom toxin tertiapin.18 The nature of basal current and IK,ACh
as inward rectifier currents was proven in each myocyte by
applying Ba2 (1 mmol/L) at the end of the experiments. The
myocytes were superfused with tyrode solution via a peristaltic
pump throughout the experiments. Drugs were applied via an
additional rapid solution exchange system (ALA Scientific In-
struments). During drug-free periods, the rapid solution exchange
system supplied tyrode solution only. Data were not corrected for
the calculated liquid junction potential (12 mV; software
JPCalc, version 2.2). To control for variability in myocyte size,
the currents are expressed as densities (pA/pF).
Single-channel currents were recorded in cell-attached config-
uration (Axopatch 200B, Axon Instruments). The bath solution
contained the following (in mmol/L): NaCl 120, KCl 20, MgCl2 1,
CaCl2 2, glucose 10, HEPES 10, pH 7.4 with NaOH. Borosilicate
glass microelectrodes were coated with Sylgard (Dow Corning)
and had tip resistances of 3 to 8 M when filled with the pipette
solution (in mmol/L: KCl 140, HEPES 10, pH 7.2 with KOH).
IK,ACh was activated by including 10 mol/L CCh into the pipette
solution; identity of IK,ACh in the absence of CCh application was
tested by applying 10 nmol/L tertiapin to the bath solution. The
single-channel characteristics of IK1 and IK,ACh were analyzed at
120 mV. The total recording time was 20 seconds for each
voltage or drug application. The open probability of the channels
was calculated from the total number of openings during 20
seconds of recording time. The average open probability per
1-second tracing was used for statistical evaluation. The single-
channel slope conductances of IK1 and IK,ACh were calculated from
the individual current-voltage relationships by linear regression
analysis.
Molecular Analysis of the G3 Gene
Direct activation of IK,ACh is mediated by -subunits of G proteins.
The G protein 3 subunit gene (GNB3) contains a C825T poly-
TABLE 1. Patient Characteristics
SR cAF
Patients, n 46 33
Gender, M/F 34/12 25/8
Age, y 66.41.5 68.61.3
Body mass index, kg/m2 27.30.5 27.00.8
CAD, n 26 11
MVD/AVD, n 8 13
CADMVD/AVD, n 12 9
Hypertension, n 35 25
Diabetes, n 18 13
Hyperlipidemia, n 35 15*
LVEF, % 56.92.4 58.22.4
LVEDP, mm Hg 14.41.1 14.11.8
LAD, mm 40.30.8 48.11.8*
LVEDD, mm 50.41.0 51.81.7
IVS, mm 11.60.4 11.80.5
LVPW, mm 11.00.3 11.60.3
Digitalis, n 2 12*
ACE inhibitors, n 32 22
AT1 blockers, n 2 2
-Blockers, n 39 29
Dihydropyridines, n 5 2
Diuretics, n 17 21*
Nitrates, n 12 7
Lipid-lowering drugs, n 29 13*
CAD indicates coronary artery disease; MVD, mitral valve disease requiring
valve replacement; AVD, aortic valve disease requiring valve replacement;
LVEF, left ventricular ejection fraction; LVEDD, left ventricular end-diastolic
diameter; LVEDP, left ventricular end-diastolic pressure; LAD, left atrial
diameter; IVS, interventricular septum thickness; LVPW, left ventricular poste-
rior wall thickness; ACE, angiotensin-converting enzyme; and AT, angiotensin
receptor.
*P0.05, values from unpaired Student t test for continuous variables
and from 2 test for categorical variables.
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morphism, whereby homozygous 825T-allele carriers exhibit larger
basal inward rectifier K current densities possibly because of
enhanced signal transduction.17 To exclude confounding by homozy-
gous 825T-allele carriers, all patients were genotyped for the C825T
polymorphism. DNA extraction and genotyping were performed in a
blinded manner as described.7 In this report the patient sample
includes homozygous and heterozygous C825-allele carriers only.
Statistical Analysis
Throughout this report, n refers to the number of myocytes/patients,
unless otherwise stated. For quantitative comparisons, average val-
ues were calculated from multiple data obtained from 1 patient.
Because the number of cells investigated varied widely in each
patient (unbalanced observations), we calculated means from aver-
age values for each patient.
One-way ANOVAs were applied to determine the sources of
K current variation (SPSS version 12.0). Independent variables
were cAF, selected clinical variables, and medication (Table 1).
Differences between group means for continuous data were
compared by unpaired Student t test or when patients with SR or
cAF were stratified by underlying disease or medication by 1-way
ANOVA and post hoc multiple comparisons tests (Bonferroni t
test). The concentration-dependent effects of tertiapin on basal
and CCh-activated current were evaluated with a mixed linear
model (with fixed factors for rhythm status and concentration of
tertiapin and random factor for subjects) followed by post hoc
Tukey-Kramer t test (SAS version 9.1). To calculate the concen-
tration of tertiapin blocking the CCh-activated IK,ACh by 50%
(IC50) in SR and cAF, the concentration-response curve of the
mean values was fitted to a 4-parameter logistic function (Prism
version 4.0). Frequency data were analyzed with 2 statistics.
P0.05 was considered statistically significant.
Results
Amplitudes of basal current and IK,ACh were related to selected
clinical variables. Significant differences between the 2
groups were found for hyperlipidemia and left atrial diameter.
Figure 1. Inward rectifier currents in
atrial myocytes from SR and cAF
patients. A, Original recordings from a
myocyte in SR (left) or cAF (right) under
basal conditions (basal current) and in
response to 2 mol/L CCh (IK,ACh was
defined as CCh-sensitive current). Top,
Ramp protocol. B, Time course of IK,ACh
analyzed at 100 mV. IK,ACh was stimu-
lated with 2 successive CCh applications
(S1, S2, 4 minutes apart) in SR (left) and
in cAF (right). During each activation, the
strong initial increase (“Peak”) of IK,ACh
faded (rapid desensitization) to a quasi–
steady state level (“Qss”). C, MeanSEM
of basal current and IK,ACh from SR and
cAF during S1 only (Vm100 mV;
*P0.05 vs SR). The numbers indicate
number of myocytes/patients.
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Patients with cAF more often received digitalis and diuretics,
whereas lipid-lowering drugs were more frequently used in
those with SR (Table 1). The patients used for the tertiapin
studies showed clinical characteristics comparable to those of
the other groups. With 1-way ANOVAs, AF was the only
predictor of basal current and IK,ACh current density (data not
shown).
Basal Current and IK,ACh in Atrial Myocytes of SR
and cAF Patients
In voltage-clamped human atrial myocytes, cell capacitances
averaged 80.34.7 pF (n136) for SR and 89.64.1 pF
(n76) for cAF myocytes (P0.05). Basal current in the
absence of agonist (Figure 1A) was confirmed to be larger in
cAF than in SR (at 100 mV: 22.92.1 pA/pF, n76/25
[myocytes/patients] versus 12.71.0 pA/pF, n136/38;
P0.05).
Application of CCh resulted in rapid initial increase
(Peak) of IK,ACh amplitude, which was followed by a
decrease to a quasi–steady state level (Qss) despite the
continuous presence of CCh (desensitization).10 There was
no difference in desensitization of IK,ACh between myocytes
from SR and cAF patients (Figure 1B), the Peak/Qss ratio
of IK,ACh being 0.580.06 (n76/25) for AF versus
0.540.03 (n136/38) for SR (PNS). As expected, the
CCh-activated Peak- and Qss-IK,ACh currents were smaller
in cAF than in SR groups (Figure 1B, 1C).
Effects of Tertiapin on Basal Current and IK,ACh
The selective IK,ACh blocker tertiapin18 was used to discrimi-
nate between IK1 and IK,ACh contribution to enhanced basal
current in AF. Tertiapin blocks IK,ACh with IC50 values between
8 and 30 nmol/L without any effect on IK1 up to 1
mol/L.16,19,20
For this set of experiments we applied CCh (2 mol/L)
twice with 4 minutes of washing in between (S1, S2). S1
served as internal control, whereas S2 was measured in the
presence of tertiapin or the nonselective M-receptor
blocker atropine. Even under control conditions, IK,ACh was
lower during S2 than during S1, suggesting incomplete
recovery from desensitization (Figure 2A, 2B). However,
the degrees of IK,ACh desensitization were similar in SR and
cAF myocytes (Figure 2C).
Application of tertiapin (0.1 to 100 nmol/L) during S2
reduced the S2/S1 ratio in a concentration-dependent man-
ner, with greater potency in cAF than in SR (logIC50: 9.1
for AF versus 8.2 for SR; P0.05; Figure 3A to 3C). In
addition, tertiapin concentration-dependently impaired
basal current in cAF, yielding a tertiapin-sensitive compo-
nent of 6.71.2 pA/pF at 10 nmol/L (n16/5; Figure
Figure 2. Repeated activation of IK,ACh by
carbachol. A, The activation of IK,ACh dur-
ing 2 successive CCh (2 mol/L) applica-
tions (S1, S2, 4 minutes apart) revealed
reduced responses during S2 in SR (left)
and in cAF (right). B, C, MeanSEM (at
100 mV) of IK,ACh at Peak and Qss and
of the corresponding ratios in SR and
cAF, respectively. The numbers indicate
number of myocytes/patients.
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3D, 3E). After subtraction of the tertiapin-sensitive current
component, basal current of cAF patients remained in-
creased (Figure 3D), suggesting enhanced IK1 in these
patients.
Tertiapin also suppressed a component of basal current
in SR; however, this amounted to only 1.70.5 pA/pF at
10 nmol/L (n24/8). Application of drug-free tyrode
solution alone caused a small decrease of basal current by
1.50.6 pA/pF (n5/4) in SR and 1.61.2 pA/pF
(n4/3) in cAF. Our results suggest constitutively active
IK,ACh channels in cAF only (Figure 3A, 3C).
The cAF patients involved in the experiments with
tertiapin did not have a history of vagally mediated AF.
Compared with SR, they had larger left atria and a higher
prevalence of diabetes, and they more frequently took
diuretics (Table 1). However, basal currents were similar
in cAF patients with and without valvular heart disease
(28.74.2 pA/pF, n21/5 versus 26.24.4 pA/pF,
n17/4) or diabetes (27.13.4 pA/pF, n28/7 versus
29.27.5 pA/pF, n10/2). The same holds true for
treatment with diuretics (27.93.5 pA/pF, n24/6 versus
26.96.2 pA/pF, n14/3). The tertiapin (10 nmol/L)-
sensitive current component was 6.41.5 pA/pF (n12/3)
and 6.31.6 pA/pF (n12/4) in the absence of diuretics
and digitalis, respectively, suggesting a lack of drug
effects on constitutively active IK,ACh channels in cAF.
Next we excluded the contribution of spontaneously
active M-receptors to enhanced basal current in cAF.
Atropine (1 mol/L) abolished the CCh-activated IK,ACh in
both groups without effect on basal currents. Thus,
tertiapin-sensitive constitutive activity of IK,ACh is indepen-
dent of M-receptors (Figure 4).
Single-Channel Activity of IK1 and IK,ACh in SR and
Chronic AF Patients
For a more direct proof of constitutive activity of IK,ACh
channels in cAF, we measured single-channel activity in the
cell-attached mode. Constitutive activity of IK,ACh was de-
tected in cAF but was minute in SR (channel open probabil-
ity: cAF, 5.40.8%, n19/9 versus SR, 0.10.01%,
n16/9; P0.05; Figure 5A to 5C). Moreover, open proba-
bility of IK1 was higher in cAF than in SR (13.40.4%,
n19/9 versus 11.40.7%, n16/9; P0.05; Figure 5D)
without changes in other channel characteristics (Table 2).
Exclusion of cAF patients taking diuretics or digitalis had no
impact on constitutive activity of IK,ACh. Open probability of
IK,ACh was 6.10.7% (n8/4) and 5.20.5% (n9/4) in the
absence of diuretics and digitalis, respectively.
Figure 3. Effects of the selective IK,ACh
blocker tertiapin on basal current and
CCh-activated IK,ACh. A, Effects of tertia-
pin (10 nmol/L) applied during S2 with S1
serving as internal control in SR and
cAF. B, C, Concentration-dependent
effects of tertiapin on the S2/S1 ratio of
IK,ACh at Peak (left) and Qss (right) in SR
and cAF patients. D, E, Concentration-
dependent block of basal current with
tertiapin in SR and cAF patients. Each
point in B, C, and E represents values
(meanSEM; at 100 mV) from n inde-
pendent experiments. Numbers within
the figures and columns indicate number
of myocytes/patients. *P0.05 vs corre-
sponding values in SR; #P0.05 vs pre-
drug control.
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Inclusion of 10 mol/L CCh in the pipette solution
caused single-channel openings in periodic bursts in all SR
and cAF myocytes studied. Amplitudes and open times of
constitutively active IK,ACh channels were not different from
those of channels activated with CCh (Table 2).
Exposure of myocytes from SR patients with tertiapin
(10 nmol/L) reduced open probability of CCh-activated
IK,ACh (Figure 6A, 6C), which is in agreement with previous
results obtained in rabbit atrial myocytes.20 Consistent
with the reduction of whole-cell basal current shown in
Figure 3C, open probability of constitutively active IK,ACh
during cAF was lower in the presence of 10 nmol/L
tertiapin without concomitant effects on IK1 (Figure 6B,
6D).
Discussion
In the present study we demonstrate that in addition to
enhanced subunit expression, increased open probability of
IK1 channels contributes to higher basal inward rectifier K
current in patients with cAF. We provide evidence for
involvement of agonist-independent constitutive activity
of IK,ACh channels from several observations: (1) the selec-
tive IK,ACh inhibitor tertiapin reduced basal current in cAF
but not in SR; (2) single-channel measurements demon-
strated spontaneous openings of IK,ACh channels in myo-
cytes from cAF patients only; and (3) the open probability
of constitutively active single IK,ACh channels during cAF
was lower in the presence of tertiapin. Evidence for
agonist-independent constitutive activity of IK,ACh was pro-
vided by the lack of block of these channels by the
M-receptor antagonist atropine. Our results suggest that in
cAF the higher basal inward rectifier K current results
from increased expression and open probability of IK1 and
constitutively active IK,ACh channels, which may contribute
to the perpetuation of the arrhythmia.
Figure 4. Effect of the nonselective
M-receptor antagonist atropine on basal
current and CCh-activated IK,ACh in SR
and cAF. A, Atropine (1 mol/L) applied
during S2 abolished CCh-activated IK,ACh.
B, Atropine did not affect basal current in
SR and cAF (meanSEM at 100 mV).
Numbers within the columns indicate
number of myocytes/patients.
Figure 5. Characteristics of IK1 and IK,ACh
single-channel activities in atrial myocytes
from SR and cAF patients. IK,ACh was acti-
vated by inclusion of 10 mol/L CCh in the
pipette. A, B, Representative unitary IK1, con-
stitutively active IK,ACh, and CCh-activated
IK,ACh currents recorded in cell-attached
patch conditions from a myocyte from SR
and cAF patient, respectively. The myocyte
from the cAF patient exhibits both IK1 and
constitutively active IK,ACh currents, whereas
the latter is a rare event in the myocyte from
the SR patient. c indicates closed channel
state. C, Current-voltage relationships of IK1
and IK,ACh and their single-channel slope con-
ductances in SR and cAF, respectively.
Holding potential (Vm) is expressed as volt-
age deviation from resting membrane poten-
tial.  indicates single-channel conductance.
D, Channel open probability of IK1, constitu-
tively active IK,ACh, and CCh-activated IK,ACh
currents (meanSEM at 120 mV). Num-
bers within the columns indicate number of
myocytes/patients. *P0.05 vs correspond-
ing values in SR.
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Comparison With Previous Studies
At the whole-cell level, several studies reported higher
amplitude of basal inward rectifier K current in cAF than in
SR patients.3,4,6,7,14,15 Pacing-induced tachycardia in dogs also
results in higher IK1 amplitude,16,21 suggesting that the in-
crease in IK1 is a consequence of the arrhythmia. Because
expression of the corresponding channel subunits at mRNA
and protein levels followed the increase in current ampli-
tude,6,15 it was concluded that modified channel subunit
transcription and/or translation is the only mechanism of
increased IK1 during human cAF. Our results at the single-
channel level, however, showed that open probability of IK1 is
slightly but significantly higher in cAF than in SR, suggesting
that the molecular basis of increased IK1 is more complex and
involves not only increased channel subunit expression but
also additional modifications of channel regulation. The
molecular mechanisms of enhanced open channel probability
of IK1 are currently unknown but may involve impaired
phosphorylation-dependent regulation. The Kir2.x channel
subunits of IK1 possess phosphorylation sites for different
kinases, and higher channel subunit phosphorylation results
in lower IK1 amplitude.22,23 Because cAF is associated with
higher activity of the counterbalancing type 1 and type 2A
serine/threonine protein phosphatases,8 it cannot be excluded
that the expected stronger channel dephosphorylation contrib-
utes to higher IK1 activity in AF. Further studies are needed to
identify the molecular mechanisms of modified IK1 regulation
in cAF patients.
Consistent with previous studies,4,6,7 we found that the
M-receptor–mediated activation of IK,ACh is smaller in cAF
than in SR patients. Moreover, reduced channel subunit
expression at the mRNA and protein level corresponds
well to the lower activation of IK,ACh in cAF.6,12,13,15
Nevertheless, we clearly demonstrated that IK,ACh becomes
constitutively active when cAF develops. The selective
IK,ACh blocker tertiapin concentration-dependently inhibited
whole-cell CCh-activated IK,ACh, with higher potency in AF
than in SR. Tertiapin blocks native IK,ACh channels with IC50
values between 8 and 30 nmol/L16,19,20 without significant
effects on other ion channels.19,20 The effective concentra-
tion range of tertiapin found in the present study (Figure 3)
is in good agreement with the reported potency. In human
atria, however, tertiapin unmasked a robust component of
constitutively active IK,ACh in cAF and a substantially
smaller one in SR. Recent findings in dog atria and
pulmonary veins detected a tertiapin-sensitive current
component contributing to basal inward rectifier current,
and, consistent with our results, pacing-induced
TABLE 2. Single-Channel Characteristics of IK1 and Constitutively Active IK,ACh in Myocytes
From SR and cAF Patients
Current
Rhythm
Status n Amplitude, pA o, ms
No. of Openings
(1 s Tracing) Po, %
IK1 SR 16/9 2.50.07 7.80.3 35.24.4 11.40.7
cAF 19/9 2.40.07 7.60.2 44.53.1 13.40.4*
IK,ACh SR 16/9 3.90.11 1.90.2 1.10.2 0.130.05
cAF 19/9 3.80.10 2.40.2 10.21.1* 5.40.7*
o indicates time constant for open time distributions; Po, channel open probability (both at holding potential of
120 mV); n, No. of myocytes/patients.
*P0.05 vs corresponding SR group.
Figure 6. Effects of tertiapin on IK1 and
IK,ACh single-channel activity in SR and
cAF myocytes. In SR, IK,ACh was activated
by inclusion of 10 mol/L CCh in the
pipette. A, C, Channel open probability
of CCh-activated IK,ACh in SR was com-
pared before (control) and after exposure
of tertiapin (10 nmol/L, meanSEM at
120 mV). In the presence of CCh, open
probability of IK1 was not analyzed (n.d.
indicates not determined). B, D, Channel
open probabilities of IK1 and constitu-
tively active IK,ACh in cAF before (control)
and after exposure to tertiapin (10
nmol/L, meanSEM at 120 mV). Num-
bers within the columns indicate number
of myocytes/patients. c indicates closed
channel state. *P0.05 vs corresponding
controls.
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tachycardia was associated with higher whole-cell current
density of this current component.16 Thus, the development
of constitutively active IK,ACh currents in human cAF is
probably a consequence of atrial remodeling contributing
to the perpetuation rather than the initiation of the
arrhythmia.
The molecular basis of constitutively active IK,ACh is
currently unknown. At the single-channel level, basal IK,ACh
activity in cAF resulted from a higher number of channel
openings and subsequent increase in channel open proba-
bility without concomitant changes in basic current prop-
erties. The basic properties of IK1 and IK,ACh were in good
agreement with previous results.24,25 Thus, the reduced
channel subunit expression in cAF6,12,13,15 is probably part
of the modified IK,ACh regulation and can be interpreted as
an adaptation on the higher frequency of IK,ACh openings in
these patients.
The regulation of IK,ACh is complex, suggesting several
putative mechanisms for constitutive activity of IK,ACh.
Because the latter was not affected by blocking
M-receptors with atropine, basal activity of IK,ACh is an
agonist-independent process. Increased agonist-
independent dissociation of G- and G-subunits of
inhibitory G proteins appears unlikely because in dog atrial
myocytes neither pertussis toxin treatment nor absence of
GTP affected the tertiapin-sensitive component of basal
current.16
Evidence for constitutive activity of atrial IK,ACh channels
was provided by earlier studies26,27 that showed that
agonist-independent activation of IK,ACh requires ATP.
Interestingly, consistent with the results from atria of dogs
with tachypacing,16 pertussis toxin treatment failed to
prevent the ATP activation of IK,ACh.26 Because activation
of IK,ACh requires ATP,26 –28 modified phosphorylation-
dependent channel regulation may contribute to the devel-
opment of constitutively active IK,ACh in cAF. Consistent
with this idea, recent publications have shown that in atrial
myocardium Kir3.1 forms a macromolecular complex,
allowing for local regulation of IK,ACh function.28,29 The
atrial GIRK1 macromolecular complex is composed of the
catalytic subunits of PKA, PKC, and CaMKII and the
protein phosphatases PP1 and PP2A.28,29 Thus, the quali-
tative and quantitative composition of the GIRK1 macro-
molecular complex may change during AF, resulting in
abnormal regulation of IK,ACh. Further work is needed to
verify these hypotheses.
Study Limitations
In the present investigation we studied regulation of IK1 and
IK,ACh only in isolated myocytes in vitro. The situation in
multicellular preparations and in vivo is more complex. Thus,
our data should be extrapolated with caution to the in situ
atria. It is well known that the atria are heterogeneous tissues.
Therefore, our data obtained in right atrial appendages may
not necessarily reflect alterations in the rest of the atria.
Digitalis, diuretics, and lipid-lowering drugs were more
frequently prescribed in cAF. Thus, we cannot exclude that
drugs affect density of IK1 and IK,ACh. Finally, our current
recordings were performed at room temperature only. Their
regulation may differ at physiological temperature.
Potential Clinical Implications
Our results show that the molecular basis for the higher
amplitude of basal inward rectifier current in AF involves
increased Kir2.x channel subunit expression6,15 and channel
open probability (present study). Two-dimensional computer
simulations of human atrial tissue showed that IK1 affects
spiral wave dynamics.30 An increase of IK1 during cAF
resulted in reduced APD and hyperpolarization of the resting
membrane potential, which is consistent with the shorter APD
and the more negative resting membrane potential of multi-
cellular trabeculae from patients with cAF.6 The changes in
APD and resting membrane potential were associated with
higher availability of the Na current (INa) and enhanced
excitability, leading to faster rotation frequencies and stabi-
lization of functional reentry. Most important, reduction of IK1
in the model was associated with APD prolongation and
depolarization, resulting in decreased rotation frequency and
spiral wave termination.30 Consistent with these findings,
mice with overexpression of the IK1 channel subunit Kir2.131
and humans with a gain-of-function mutation of this channel
develop cAF.32 Thus, blockade of IK1 may be a viable
antiarrhythmic option.
In analogy to IK1, constitutively active IK,ACh may con-
tribute to stabilization of functional reentry because in
ACh-induced AF in sheep, the higher activation frequen-
cies in left atria are associated with larger density of
IK,ACh.33 In vivo, vagal nerve stimulation abbreviates APD
and increases APD heterogeneity and atrial vulnerability to
tachyarrhythmia,34 which perpetuate AF.9 In knockout
mice lacking the Kir3.4 channel subunit of IK,ACh,
M-receptor stimulation did not induce AF,11 suggesting
that the effects of vagal nerve activation are mediated by
IK,ACh. Thus, the agonist-independent constitutive activa-
tion of IK,ACh during cAF is expected to increase atrial
vulnerability to tachyarrhythmia and to sustain AF. Be-
cause some antiarrhythmic drugs such as amiodarone,
flecainide, quinidine, and verapamil, which effectively
terminate AF,35 are also inhibitors of IK,ACh,36 –38 it cannot
be excluded that their effectiveness in AF results in part
from blockade of IK,ACh and that at least in some patients
with AF the inhibition of constitutively active IK,ACh may
have an antiarrhythmic affect.
Finally, there is evidence of circulating M2 autoantibod-
ies in AF patients, which may exert a tonic activation of
M-receptor signal transduction.39 Furthermore, the ACh
concentrations in the synaptic clefts could be elevated
because of reduced activity of its degrading enzyme
acetylcholine esterase.40 Because atropine had no effect on
basal current in cAF, the development of constitutively
active IK,ACh channels occurs in a receptor-independent
manner. Thus, it is likely that the elevated synaptic ACh
concentrations and the presence of M2 autoantibodies and
constitutively active IK,ACh channels reinforce each other in
promoting AF. Further studies are needed to test these
hypotheses.
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Conclusions
We demonstrated that the molecular basis of higher basal
inward rectifier K current in patients with cAF involves
increased density of IK1 and development of constitutively
active IK,ACh. Our results provide a mechanistic insight into the
regulation of IK1 and IK,ACh in cAF that may help to design new
therapeutic options for AF.
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CLINICAL PERSPECTIVE
Vagal nerve stimulation can provoke atrial fibrillation (AF) requiring activation of the acetylcholine-gated potassium
channels. The resulting IK,ACh current shortens action potential duration, increases repolarization heterogeneity, and
enhances atrial vulnerability to tachyarrhythmia. Chronic AF is associated with changes in electrophysiological properties
that promote initiation and maintenance of the arrhythmia. These electrical remodeling processes involve IK,ACh, although
the underlying molecular mechanisms are unknown. Here we applied voltage-clamp techniques to analyze background
inward rectifier potassium current and IK,ACh in chronic AF. We found that IK,ACh shows strong activity despite the absence
of acetylcholine or analogous pharmacological stimulation. This receptor-independent, constitutive activity of IK,ACh in
chronic AF may be of considerable clinical relevance because it could serve as a therapeutic target for termination of AF
and maintenance of SR after cardioversion.
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